Full Breakdown
Rising Rates of Rectal Cancer Among Younger Adults
3/3/2026, 1:44:00 AM
Core Event: Surge in Rectal Cancer Diagnoses
A recent report from the American Cancer Society indicates a significant rise in rectal cancer rates, particularly among adults under 65. This demographic now accounts for nearly half (45%) of new colorectal cancer diagnoses, a sharp increase from 27% in 1995. While colorectal cancer rates are declining in individuals aged 65 and older, rectal cancers are on the rise across all age groups, comprising nearly one-third of all colorectal cancer cases.
Background & Context: Changing Demographics of Colorectal Cancer
Historically viewed as a disease primarily affecting older adults, colorectal cancer is increasingly being diagnosed in younger populations. The report highlights that between 2018 and 2022, rectal cancer diagnoses rose by 1% annually across all age groups. This trend is attributed to a "birth-cohort effect," where successive generations, particularly those born in the 1950s and later, show progressively higher risks of developing colorectal cancers. For instance, individuals born in 1990 are twice as likely to develop colon cancer and four times more likely to develop rectal cancer compared to those born in 1950.
Key Figures & Groups: Experts Weigh In
Dr. Arif Kamal, chief patient officer for the American Cancer Society, emphasized the alarming nature of this trend, stating, “We didn’t have an epidemic of young people with colon or rectal cancer up until recently.” Dr. William Dahut, chief scientific officer of the American Cancer Society, noted that colorectal cancer was traditionally considered "Grandpa’s disease," highlighting the demographic shift. Cancer epidemiologist Rebecca Siegel pointed to potential environmental or behavioral factors introduced in the latter half of the 20th century as possible contributors to this increase.
Why It Matters: Implications for Screening and Awareness
The rising incidence of colorectal cancer in younger adults necessitates a reevaluation of screening guidelines. In 2021, the U.S. Preventive Services Task Force lowered the recommended screening age from 50 to 45. However, only about one-third of individuals aged 45 to 49 are currently being screened. The report indicates that approximately 75% of colorectal cancers in those under 50 are diagnosed at advanced stages, underscoring the need for timely diagnosis and treatment.
Criticism & Opposition: Calls for Increased Awareness
Experts are advocating for greater awareness and education regarding colorectal cancer symptoms, particularly among younger populations. Caitlin Murphy, a cancer epidemiologist, noted that patients often experience delays in diagnosis due to referral loops within the healthcare system. Laura Behnke, a late-stage colon cancer survivor, shared her experience of misdiagnosis, emphasizing the importance of normalizing discussions about symptoms like bloody stool.
Official Statements & Responses
The American Cancer Society's report calls for increased awareness and education about colorectal cancer, particularly for younger adults. Dr. Kamal stated, “There will be decisions to be made within the next couple of years” regarding screening practices, reflecting the urgency of addressing this public health issue.
Verbatim Quotes
- “We didn’t have an epidemic of young people with colon or rectal cancer up until recently,” — Dr. Arif Kamal, American Cancer Society
- “This isn’t necessarily an age-specific thing — this is a generational thing,” — Andreana Holowatyj, Vanderbilt University Medical Center
- “It's so important for people to have these conversations with their family at the dinner table,” — Rebecca Siegel, American Cancer Society
What's Next: Future Directions in Research and Screening
As colorectal cancer diagnoses continue to trend younger, further research is needed to identify the underlying causes of this increase. Experts anticipate that screening guidelines may be revised in the coming years to address the growing incidence of colorectal cancer in younger adults. Increased public awareness and education about symptoms and screening options are critical to reversing this troubling trend.
